Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Clinical care

Diagnostics Microbiology and immunology

Out With the Old

| Luke Turner

Existing tests for rapid diagnosis of TB are costly and insufficient – but second-generation assays with improved sensitivity could be the answer

Outside the Lab Clinical care

The Integration Equation

| W. Dean Wallace, Robert Suh

Pathologists and radiologists must work closely together to provide the best possible patient care

Subspecialties Clinical care

An Inside Look at the CNS

| Danielle Fortuna, Mark Curtis

Neurological disorders can be invasive and time-consuming to diagnose, but profiling cytokines in the cerebrospinal fluid can lessen that burden

Outside the Lab Clinical care

Career Advice – In Brief

| Michael Schubert

Pathologists and laboratory medicine professionals take to social media to share the best career advice they’ve ever received

Diagnostics Clinical care

Act Fast Against Infection

| Matthieu Legrand

To confront the increasing problem of antimicrobial resistance in medicine, laboratorians and clinicians must pursue rapid diagnostics

Inside the Lab Clinical care

Positive Steps to Tackle Triple-Negative Breast Cancer

| Jane Armes

Jane Armes discusses the value of molecular subtyping and targeted therapies in triple-negative breast cancer

Diagnostics Histology

Case of the Month

Can you determine the hereditary syndrome that this renal tumor is indicative of?

Subspecialties Microbiology and immunology

A Win-Win-Win Situation

| Bamidele Farinre

How consolidating molecular diagnostics has improved service delivery for the Great Ormond Street Hospital microbiology department

Diagnostics Biochemistry and molecular biology

Treat or Surveil

| George Vasmatzis and John Cheville

Newly discovered genetic alterations could indicate whether treatment or active surveillance is the best option for low-risk prostate cancer patients

Diagnostics Clinical care

MDLUX2: Drawing a Fuller Picture

| Michael Schubert

Luxembourg’s new molecular diagnostics program aims to establish the value of such analyses as a part of routine cancer care

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register